The global liquid biopsy market was valued at USD 10.85 billion in 2023, increasing at a CAGR of 11.61% from 2024 to 2033 and anticipated to reach USD 32.54 billion by 2033. Asia-Pacific is expected to grow the fastest during the forecast period. The increasing awareness about the availability of various non-invasive treatments is anticipated to drive market growth.
https://www.thebrainyinsights.com/report/liquid-biopsy-market-13005
Le contenu envoyé sera déplacé vers cet album nouvellement créé. Vous devez créer un compte ou se connecter si vous souhaitez modifier cet album plus tard.